NCT01277146View on ClinicalTrials.gov

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Solid Tumors
Interventions
DRUG

OMP-59R5

IV infusion

Trial Locations (2)

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

78229

South Texas Accelerated Research Therapeutics, San Antonio

Sponsors
All Listed Sponsors
lead

OncoMed Pharmaceuticals, Inc.

INDUSTRY